111 related articles for article (PubMed ID: 8255193)
1. Quantitative proton spectroscopy and histology of a canine brain tumor model.
Barker PB; Blackband SJ; Chatham JC; Soher BJ; Samphilipo MA; Magee CA; Hilton JD; Strandberg JD; Anderson JH
Magn Reson Med; 1993 Oct; 30(4):458-64. PubMed ID: 8255193
[TBL] [Abstract][Full Text] [Related]
2. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R
AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583
[TBL] [Abstract][Full Text] [Related]
3. Effects of therapy on the 1H NMR spectrum of a human glioma line.
Cazzaniga S; Schold SC; Sostman HD; Charles HC
Magn Reson Imaging; 1994; 12(6):945-50. PubMed ID: 7968293
[TBL] [Abstract][Full Text] [Related]
4. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
Ziegler A; von Kienlin M; Décorps M; Rémy C
Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
[TBL] [Abstract][Full Text] [Related]
5. Multivoxel proton magnetic resonance spectroscopy of inflammatory and neoplastic lesions of the canine brain at 3.0 T.
Stadler KL; Ober CP; Feeney DA; Jessen CR
Am J Vet Res; 2014 Nov; 75(11):982-9. PubMed ID: 25350088
[TBL] [Abstract][Full Text] [Related]
6. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.
Heesters MA; Kamman RL; Mooyaart EL; Go KG
J Neurooncol; 1993 Jul; 17(1):27-35. PubMed ID: 8120569
[TBL] [Abstract][Full Text] [Related]
7. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
9. Localized proton spectroscopy of focal brain pathology in humans: significant effects of edema on spin-spin relaxation time.
Kamada K; Houkin K; Hida K; Matsuzawa H; Iwasaki Y; Abe H; Nakada T
Magn Reson Med; 1994 May; 31(5):537-40. PubMed ID: 8015407
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro.
Xu YJ; Cui Y; Li HX; Shi WQ; Li FY; Wang JZ; Zeng QS
Magn Reson Imaging; 2016 Oct; 34(8):1121-7. PubMed ID: 27215950
[TBL] [Abstract][Full Text] [Related]
12. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors.
Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y
Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553
[TBL] [Abstract][Full Text] [Related]
13. Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1H NMR spectroscopic imaging.
Segebarth CM; Balériaux DF; Luyten PR; den Hollander JA
Magn Reson Med; 1990 Jan; 13(1):62-76. PubMed ID: 2319936
[TBL] [Abstract][Full Text] [Related]
14. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
García-Martín ML; Hérigault G; Rémy C; Farion R; Ballesteros P; Coles JA; Cerdán S; Ziegler A
Cancer Res; 2001 Sep; 61(17):6524-31. PubMed ID: 11522650
[TBL] [Abstract][Full Text] [Related]
15. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
Balmaceda C; Critchell D; Mao X; Cheung K; Pannullo S; DeLaPaz RL; Shungu DC
J Neurooncol; 2006 Jan; 76(2):185-91. PubMed ID: 16151595
[TBL] [Abstract][Full Text] [Related]
16. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of intracranial neoplasia and noninfectious meningoencephalitis in dogs by use of short echo time, single voxel proton magnetic resonance spectroscopy at 3.0 Tesla.
Carrera I; Richter H; Beckmann K; Meier D; Dennler M; Kircher PR
Am J Vet Res; 2016 May; 77(5):452-62. PubMed ID: 27111012
[TBL] [Abstract][Full Text] [Related]
19. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
20. Assessment of alterations in X-ray irradiation-induced DNA damage of glioma cells by using proton nuclear magnetic resonance spectroscopy.
Li H; Xu Y; Shi W; Li F; Zeng Q; Yi C
Int J Biochem Cell Biol; 2017 Mar; 84():109-118. PubMed ID: 28122253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
